1. Zimmenmann D, Janin YL, Brehm L, Bräuner-Osborne H, Ebert B, Johansen TN, et al. 3-Pyrazolone analogues of 3-isoxazol metabotropic exicatory amino acid receptor angonist homo-AMPA: synthesis and pharmacological testing. Eur J Med Chem. 1999;34:967–975.
2. Froesti W, Furet R, Hall RC, Micekl SJ, Strub D, von Sprecher G, et al. GABAB antagonists: novel CNS-active compounds: In: Testa B, Kybruz E, Fuhrer W, Giger R, eds. Perspectives in Medicinal Chemistry. New York, NY: VHC, 1993:259–272.
3. Dickneite G, Schwab W, Schorlemmer HU, Gebert U, Sdelacek HH. Effect on the immunostimulator HAB 439 on cell-mediated immunity against intracellular bacteria. Int J Immunopharmacol. 1991;13:541–548.
4. Mills SG, Hale JL, MacCoss M, Dorn CP, Finke PE, Budhu RJ, et al. Physical and biological properties of water-soluble prodrugs of morphonine acetal substance P antagonists. 213th American College of Surgeons National Meeting, San Francisco, Ca., April 13–17, 1997.
5. Morain R, Lestage P, Roger A, Bobichon C, Desos P, Cordi A, Lepagnol J 1995, S 17625, a selective and competitive non-NMDA antagonist: cerebral anti-ischemic effects in rodents. Br. J Pharmacol. (Proc. Suppl.) 1995;114:339P.